The effect of intensive risk factor management in type 2 diabetes on inflammatory biomarkers

Goff, 2007, Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial, Am J Cardio, 99, 4i, 10.1016/j.amjcard.2007.03.002 Pradhan, 2001, C-reactive protein interleukin 6, and risk of developing type 2 diabetes mellitus, JAMA, 286, 327, 10.1001/jama.286.3.327 Danesh, 2004, C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease, N Engl J Med, 350, 1387, 10.1056/NEJMoa032804 Lloyd-Jones, 2006, Narrative review: assessment of C-reactive protein in risk prediction for cardiovascular disease, Ann Intern Med, 145, 35, 10.7326/0003-4819-145-1-200607040-00129 Ndumele, 2006, Interrelationships between inflammation, C-reactive protein, and insulin resistance, J Cardiometab Syndr, 1, 190, 10.1111/j.1559-4564.2006.05538.x Goldberg, 2009, Cytokine and cytokine-like inflammation markers: endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications, J Clin Endocrinol Metab, 94, 3171, 10.1210/jc.2008-2534 Rizvi, 2009, Cytokine biomarkers, endothelial inflammation, and atherosclerosis in the metabolic syndrome: emerging concepts, Am J Med Sci, 338, 310, 10.1097/MAJ.0b013e3181a4158c Haffner, 2006, The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease, Am J Cardiol, 97, 3A, 10.1016/j.amjcard.2005.11.010 Swellam, 2009, Clinical implications of adiponectin and inflammatory biomarkers in type 2 diabetes mellitus, Dis Markers, 27, 269, 10.1155/2009/703927 Nguyen, 2008, Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004, J Am Coll Surg, 207, 928, 10.1016/j.jamcollsurg.2008.08.022 Farah, 2008, Intensification of oxidative stress and inflammation in type 2 diabetes despite antihyperglycemic treatment, Cardiovasc Diabetol, 22, 7 Devaraj, 2007, Statins and biomarkers of inflammation, Curr Atheroscler Rep, 9, 33, 10.1007/BF02693938 Pradhan, 2009, Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes. The LANCET Randomized Trial, JAMA, 302, 1186, 10.1001/jama.2009.1347 Schaumberg, 2005, Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the Diabetes Control and Complications Trial, Circulation, 111, 2446, 10.1161/01.CIR.0000165064.31505.3B The ACCORD Study Group, 2007, Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: design and methods, Am J Cardio, 99, 21i Gerstein, 2007, Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial, Am J Cardio, 99, 34i, 10.1016/j.amjcard.2007.03.004 Cushman, 2007, Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial, Am J Cardio, 99, 44i, 10.1016/j.amjcard.2007.03.005 Ginsberg, 2007, Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial, Am J Cardio, 99, 56i, 10.1016/j.amjcard.2007.03.024 Action to Control Cardiovascular Risk in Diabetes Study Group, 2008, Effects of intensive glucose lowering in type 2 diabetes, N Engl J Med, 358, 2545, 10.1056/NEJMoa0802743 ACCORD Study Group, 2010, Effects of intensive blood pressure control in type 2 diabetes Mellitus, N Engl J Med, 362, 1575, 10.1056/NEJMoa1001286 ACCORD Study Group, 2010, Effects of combination lipid therapy in type 2 diabetes mellitus, N Engl J Med, 362, 1563, 10.1056/NEJMoa1001282 Ismail-Beigi, 2010, Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomized trial, Lancet, 376, 419, 10.1016/S0140-6736(10)60576-4 ACORD Study Group, 2011, Long-term effects of intensive glucose lowering on cardiovascular outcomes, N Engl J Med, 364, 818, 10.1056/NEJMoa1006524 Williamson, 2007, The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods, Am J Cardio, 99, 112i, 10.1016/j.amjcard.2007.03.029 Cukierman-Yaffe, 2009, Diabetes Care, 32, 221, 10.2337/dc08-1153 Aviles-Santa, 2006, Insulin therapy, glycemic control, and cardiovascular risk factors in young Latin Americans with type 2 diabetes mellitus, J Investig Med, 54, 20, 10.2310/6650.2005.05012